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which include BML depth as well as size may be more valid than scoring
systems not including BML depth.
Figure 1. Diagram of BML scoring system (tibia).
Table 1: Comparison of mean change in cartilage parameters by BML category
CMT CMF
n volume
normalized
(mm, 95%CI)
denuded area
(mm2, 95%CI)
n volume
normalized
(mm, 95%CI)
denuded area
(mm2, 95%CI)
Large and distant 43 −0.06
(−0.1, −0.02)
35.5
(17.7, 53.3)
27 −0.10
(−0.2, 0.02)
64.25
(32.0, 96.5)
Large and close 9 −0.05
(−0.1, 0.03)
12.2
(−26.3, 50.8)
4 0.03
(−0.2, 0.2)
−29.00
(−112.8, 54.9)
Small and distant 34 0.02
(−0.03, 0.1)
−2.94*
(−22.7, 16.8)
43 −0.05
(−0.1, 0.01)
4.56*
(−21.0, 30.2)
Small and close 64 0.01
(−0.02, 0.03)
0.29*
(−14.2, 14.8)
76 −0.02
(−0.1, 0.03)
6.50*
(−12.8, 25.8)
*p< 0.05 compared to large and distant after controlling for age, gender and BMI. CMT=central
medial tibia; CMF=central medial femur.
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OSTEOARTHRITIS – A MULTIVENDOR MR SCANNER
COMPARISON STUDY AT 3.0T
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KINGDOM, 3MARIARC, University of Liverpool, Liverpool, UNITED
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Purpose: The aim of this study is to investigate whether cartilage thick-
ness, measured from MR, is comparable between 3 different vendors’
3T scanners. The ability to use different centres/vendors’ scanners would
facilitate patient recruitment and data acquisition in studies of Osteoarthri-
tis (OA). The NIH OA Initiative uses Siemens scanners, but both Philips
Medical Systems and GE Healthcare also manufacture 3T scanners.
Methods: 12 subjects with knee symptoms of OA and one or more risk
factors had their symptomatic knee scanned on each of the 3 vendor’s
scanners. Mean age 49.3±10 years (range 32−59 y); mean BMI 28.3±6.2
(range 22.1−44.2). The MR systems are located in three sites in the UK:
Manchester (Philips), York (GE), Liverpool (Siemens). The NIH OAI study
protocol was used for the Siemens scanner and corresponding protocols
were developed for the Philips and GE scanners in collaboration with
the vendors. The RF coils used were transmit-receive (GE), receive-only
(Siemens) and 8-channel phased-array (Philips). To enable intra-scanner
analysis, following the Philips acquisition, subjects were repositioned and
the sagittal 3D sequence repeated.
Manual cartilage segmentation of the sagittal 3D sequence was per-
formed by a single observer, blinded to subject identity, using EndPoint
software (Imorphics, Manchester, UK). Subchondral bone was auto-
matically segmented using a statistical appearance model to deﬁne a
reference bone shape in each image which provided a dense set of
60,456 and 39,238 anatomically corresponding points on the subchondral
bone surfaces of the distal femur and proximal tibia respectively. Cartilage
thickness was measured above each corresponding point and mean
thickness (ThCtAB) was computed within anatomical trimmed regions,
also deﬁned using the correspondences.
Results: The ﬁgure shows intra-scanner (Philips) and inter-scanner
agreement for all scanner pairs for ThCtAB within the trimmed central
medial femur (cMF) region and demonstrates small systematic differ-
ences. The intra-scanner mean difference was 0.03mm. Inter-scanner
mean differences ranged from 0.05mm to 0.2mm. The table shows the
intra-scanner and inter-scanner root mean square coefﬁcient of variation
(RMS CoV) for the ThCtAB measure for a selection of regions. These
range from 2.4%-4.6% (intra-scanner) and 4.2% to 7.7% (inter-scanner).
Figure 1. Bland and Altman plot demonstrating intra-scanner and in-
terscanner agreement. P1=Philips 1st scan, P2=Philips 2nd scan,
S=Siemens, G=GE.
ThCtAB: RMS COVs. (c)MF/T= (central) medial femur/tibia, (c)LF/T= (central) lateral femur/tibia
Region RMS CoV (%)
Intra-scanner Inter-scanner
P G&S P&S P&G P&G&S
MF 2.77 5.15 5.81 7.31 6.11
cMF 3.21 5.62 5.41 9.61 7.16
LF 3.61 4.20 4.90 7.19 5.57
cLF 2.63 5.11 4.11 6.58 5.34
MT 4.64 7.65 5.77 5.36 6.30
LT 4.08 7.69 4.00 8.07 6.95
Conclusions: This is the ﬁrst report which compares knee cartilage
thickness measures taken from 3T MR images acquired using three
different vendors’ scanners in OA subjects. Intra-scanner precision errors
are in line with other studies. Systematic differences between vendors’
cartilage thickness results are comparable with intra-scanner variability.
Increased variability was exhibited between the Philips and GE scanners
which may be due to differences in RF coil technology or image post-
processing.
Acknowledgments: C. Bos (Philips Medical Systems), S. Dezonie (GE
Healthcare), G. Green (YNIC, York). L. Gregory (TIU, Manchester), and
AstraZeneca (Macclesﬁeld), Imorphics.
Inﬂammation, Angiogenesis & Synovial
Tissue Biology
429 ANGIOGENIC INDUCTION BY MECHANICAL SIGNALS
REQUIRES ACTIVATION OF AKT PATHWAY VIA VEGF
RECEPTOR-2 IN OSTEOARTHRITIC JOINTS
J. Liu, S. Agarwal. The Ohio State University, Columbus, OH, USA
Purpose: A rapid increase in the angiogenic invasion of the pannus
and synovial membrane caused by mechanical trauma is a critical event
necessary for the initiation of cartilage and subchondral bone destruction
in osteoarthritis (OA). However, the exact intracellular mechanisms of
angiogenic responses induced by trauma remain unclear. In this study,
we hypothesize that unbalanced mechanical forces applied to the synovial
joint can drive angiogenesis through the activation of Akt pathway via
VEGF receptors and is necessary for the development of OA.
Methods:Well characterized CD31+/vWF+ human dermal microvascular
endothelial cells (HDMEC) were grown on ﬂexible bottom Bioﬂex II
plates (Flexcell Int, NC). HDMEC were exposed to various magnitudes
(3%, 6%, 12%) and frequencies (0.25Hz, 0.1Hz, 0.05Hz) of dynamic
equibiaxial tensile strain (DTS) for different time intervals. Il-1b (2 ng/ml)
was used to mimic inﬂammatory conditions of the OA joints. Inhibitors to
various kinases were used to conﬁrm the actions of mechanical signals.
Subsequently, proteins or RNA were extracted. Activation of kinases
involved in Akt pathway were examined by Western blot analysis and
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Immunoﬂuorescence using phospho-speciﬁc antibodies (Cell Signaling,
CA) to each kinase. The gene regulation was examined by real time
PCR.
Results: The examination of the Akt pathway in response to various
magnitudes of DTS demonstrated that mechanical forces regulate AKT
phosphorylation at Ser 473 in a magnitude dependent manner, and the
optimal activation occurs in response to 6% DTS. No apparent differences
in Akt activation were observed between 0.25 to 0.05Hz frequencies of
DTS. Further examination of the upstream events revealed that DTS at
6% and 0.25Hz induces phosphorylation of VEGF receptor 2 (VEGFR2)
at Tyr 1175 and drives the nuclear translocation of phospho-VEGFR2. The
nuclear translocation of phospho-VEGFR2 in HDMEC is rapid and sus-
tained, and can be observed between 5 and 60 minutes, thereafter it re-
translocates to the cytoplasm (Figure 1). The phosphorylation of VEGFR2
is paralleled by its increased mRNA expression and its synthesis. DTS-
induced phosphorylation of VEGFR2 is a prerequisite for Akt Ser 473
phosphorylation, as SU5416, a competitive inhibitor of VEGFR2, inhibits
Akt activation (Figure 2). VEGFR2 induced Akt activation is mediated
by PI-3-kinase (phosphoinositide 3-kinase). This is evident by the fact
that addition of PI-3 kinase inhibitor LY294002 can block DTS-mediated
activation of Akt. Subsequent analysis of downstream elements of DTS
actions demonstrated that DTS induced Akt phosphorylation is followed
by GSK3b (Glycogen synthase kinase-3b) phosphorylation at Ser 9 to
inactivate GSK3b, which in turn may stabilize cyclin D1 and result in a
prolongation of cyclin D1 half life. And the stabilization of cyclin D1 by
PI-3 kinase-Akt pathway can lead to the up-regulation of the cell cycle
progression essential for angiogenesis.
Conclusions: Mechanical imbalance/trauma applied to the joints trigger
angiogenesis through activation of the VEGFR2/PI 3-kinase/Akt pathway.
Such irreparable dynamics of post-translational activation of proteins
and induction of required genes may be critical in the upregulation of
angiogenesis in osteoarthritic joints by mechanical forces.
Figure 1. DTS induces rapid and sustained nuclear translocation of
phosphor-VEGFR2 between 5 and 60min, which is followed by its cy-
toplasmic re-translocation at 120min (arrows).
Figure 2. DTS induces VEGF-R2 phosphorylation in the absence and
presence of IL-1b, which can be suppressed by its competitive inhibitor
SU5416.
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Purpose: Zerumbone is the crystalline sesquiterpene derived from Zin-
giber zerumbet. Many works have been done on its effect on cancer
cells but none on arthritis. The current work was conducted to evaluate
the effect of zerumbone on the innervation of synovial membrane in
collagenase induced osteoarthritis.
Methods: Twenty male adult Sprague Dawley rats were used in this study.
Osteoarthritis was induced by injecting collagenase into the knee joint at
D1 and D4. The rats were supplemented with either 0.5ml corn oil (control
group; n = 10) or 0.5ml of 0.5ml of 0.02% w/v zerumbone in corn oil
from D7 to D21. At D22 the rats were sacriﬁced and synovial membrane
samples were processed for immunohistochemistry work. Gross changes
were also evaluated.
The ﬁxed synovial membranes were processed following a standard
method. Brieﬂy the samples were frozen in liquid nitrogen and sec-
tioned at 6mm. The sections were dehydrated in ethanol, rinsed in 0.1M
phosphate buffered saline (PBS), and then incubated in primary antisera
against protein gene product 9.5 (PGP 9.5) and calcitonin gene-related
peptide (CGRP). Sections were then incubated in secondary antiserum
and subsequently with avidin bitinylated HRP complex. Finally sections
were immersed in glucose diaminobenzidine nickel substrate, washed in
distilled water and stained with hematoxyline.
Results: Innervation of PGP 9.5- and CGRP-immunoreactive ﬁbres from
control group showed very few nerve ﬁbres in the intimal and subintimal
layer. In some samples, no nerve ﬁbres were detected in both these
regions (Fig. 2). The synovial membrane was heavily inﬁltrated with
inﬂammatory cells and blood vessels were abundantly found in the
subintimal layer.
However, density of the PGP 9.5- and CGRP-immunoreactive ﬁbres in
the synovial membrane was improved in zerumbone treated group. There
were more immunoreactive nerve ﬁbres in the intimal and subintimal layer
in the zerumbone treated group (Fig. 1). Apart from these changes, the
synovial membrane ws less inﬁltrated with inﬂammatory cells.
Figure 1: PGP 9.5 Immunoreactive nerve ﬁbres in zerumbone treated
group.
Figure 2: PGP 9.5 immunoreactive nerve ﬁbres in the control group. Very
few nerve ﬁbres were found in the synovial membrane.
Conclusions: In this preliminary study, inﬂammation of arthritis synovial
membrane was reduced in joints treated with zerumbone as evidenced
by the histological changes and in the overall innervation of the synovial
membrane in comparison to the control. The anti-inﬂammatory mecha-
nism of zerumbone on the osteoarthritis joint is beyond the scope of the
present study. However, the improvement in the immunoreactive nerve
ﬁbres suggested that zerumbone could help in remodeling of collagen via
synthesis of inter- and intra-molecular protein cross linking. This action
would help strengthen the structure of the articular cartilage. As a result,
there would be marked reduction in the inﬂammatory cells in the synovial
membrane as seen in this study, preventing loss of immunoreactive ﬁbres
from the synovial membrane.
Results from this study indicate that zerumbone could be a useful
alternative treatment in osteoarthritis. However, additional studies of
zerumbone should be undertaken to determine value of zerumbone as a
chondroprotective agent.
